The PCRI conference last month generated a lot of excitement. Exceptional doctors on the leading edge of prostate cancer research talked about how to combine new treatments in ways that haven’t been previously done and using new imaging technology to help choose optimal treatment.
- Dr. Robert Princenthal discussed how advancements in MRI technology allows for better active surveillance, less invasive monitoring without relying on repeated random biopsies
- Dr. Eugene Kwon from the Mayo Clinic remarked, "Sometimes we need to go for curative outcomes—rather than palliative ones—if we have the capability of doing so." He showed that a PET Choline scan can be used to generate a tailored multimodality treatment plan that maximizes curative potential in men with advanced stage disease.
- Dr. Snuffy Myers presented the results of a new landmark study: Men with advanced disease were evaluated by comparing Lupron alone (standard care) versus Lupron plus Taxotere. Longevity was improved by 17 months for the men receiving the combination.
The PCRI is on the cutting edge of prostate cancer care, covering new information the moment that it becomes available and relevant. This information and much more will be on the 2014 Conference DVDs. Reserve yours today.